Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer’s Disease

Background: Mood disorders represent a risk factor for dementia and are present in over 60% of cases with Alzheimer’s disease (AD). More than 80% variability in drug pharmacokinetics and pharmacodynamics is associated with pharmacogenetics. Methods: Anxiety and depression symptoms were assessed in 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Cacabelos, Ramón, Carril, Juan C., Corzo, Lola, Fernández-Novoa, Lucía, Pego, Rocío, Cacabelos, Natalia, Cacabelos, Pablo, Alcaraz, Margarita, Tellado, Iván, Naidoo, Vinogran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071277/
https://www.ncbi.nlm.nih.gov/pubmed/33920985
http://dx.doi.org/10.3390/ph14040366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071277/
https://www.ncbi.nlm.nih.gov/pubmed/33920985
http://dx.doi.org/10.3390/ph14040366

Ejemplares similares